STK11 and neoplasm: Interestingly, the PD-L1 Tumor Proportion Score (TPS) tended to be lower in the patients with vs. without STK11 mutations (0% vs. 15%), and the TMB score tended to be higher in patients with STK11 mutations (209 vs. 146) [73].